FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Vectors patents



      
           
This page is updated frequently with new Vectors-related patent applications. Subscribe to the Vectors RSS feed to automatically get the update: related Vectors RSS feeds. RSS updates for this page: Vectors RSS RSS


Date/App# patent app List of recent Vectors-related patents
10/09/14
20140304859
 Polypeptides having endoglucanase activity and polynucleotides encoding same patent thumbnailPolypeptides having endoglucanase activity and polynucleotides encoding same
Provided are isolated polypeptides having endoglucanase activity and polynucleotides encoding the polypeptides. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides..
10/09/14
20140303355
 Humanized anti-factor d antibodies and uses thereof patent thumbnailHumanized anti-factor d antibodies and uses thereof
The invention relates to humanized anti-human factor d monoclonal antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease..
10/09/14
20140303077
 Albumin fusion proteins patent thumbnailAlbumin fusion proteins
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells.
10/09/14
20140302586
 Variants of a family 44 xyloglucanase patent thumbnailVariants of a family 44 xyloglucanase
The present invention relates to variants of a parent xyloglucanase. The present invention also relates to polynucleotides encoding the variant xyloglucanases and to nucleic acid constructs, vectors, and host cells comprising the polynucleotide..
10/09/14
20140302561
 3s-rhamnose-glucuronyl hydrolase, method of production and uses patent thumbnail3s-rhamnose-glucuronyl hydrolase, method of production and uses
The present invention relates in particular to proteins, coding nucleic acid sequences for same, vectors comprising said coding sequences, a method for producing said proteins, and an oligosaccharide hydrolysis method using same. In particular, the invention relates to the protein of sequence seq id no.
10/09/14
20140302530
 Cmv glycoproteins and recombinant vectors patent thumbnailCmv glycoproteins and recombinant vectors
This invention also relates to recombinant vectors expressing one or more of the human cmv (hcmv) glycoproteins us2, us3, us6 and us11 or corresponding functional rhesus cmv (rhcmv) homologues rh182, rh184, rh185 or rh189, methods of making them, uses for them, expression products from them, and uses for the expression products. This invention also relates to recombinant cytomegalovirus vectors vectors lacking one or more of the glycoproteins, methods of making them, uses for them, expression products from them, and uses for the expression products..
10/09/14
20140302512
 Genotoxicity testing patent thumbnailGenotoxicity testing
The present invention relates to methods for detecting for the presence of an agent that putatively causes or potentiates dna damage comprising subjecting a cell (containing a dna sequence encoding gaussia luciferase (gluc) reporter protein operatively linked to a human gadd45α gene promoter and a human gadd45α gene regulatory element arranged to activate expression of the dna sequence in response to dna damage) to an agent; and monitoring the expression of the gluc reporter protein from the cell. The invention also concerns expression cassettes, vectors and cells which may be used according to such a method and also modified media that may be employed in assays and in preferred embodiments of the method of the invention..
10/09/14
20140302508
 Dna polymerases with increased 3'-mismatch discrimination patent thumbnailDna polymerases with increased 3'-mismatch discrimination
Disclosed are mutant dna polymerases having increased 3′-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods.
10/09/14
20140302507
 Dna polymerases with increased 3'-mismatch discrimination patent thumbnailDna polymerases with increased 3'-mismatch discrimination
Disclosed are mutant dna polymerases having increased 3′-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods.
10/09/14
20140302080
 Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using same patent thumbnailStabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using same
The invention features stabilized human immunodeficiency virus (hiv) envelope (env) trimers. The invention also features vaccines, nucleic acids, and vectors to deliver and/or facilitate production of the stabilized hiv env trimers.
10/09/14
20140302076
Immunogenic compositions and methods therefor
The present invention provides compositions relating to viral capsomeres which comprise foreign immunogenic sequences for use in pharmaceutical compositions and methods of producing such compositions, and related isolated or purified protein and nucleic acid molecules, vectors, host cells, compositions, and methods of use to augment an immune response, immunise an animal and prophylactically or therapeutically treat a disease, disorder or condition. The viral capsomere may be derived from a polyomavirus and comprise an immunogen of interest at the n-terminus and further at the c-terminus and/or at one or more exposed loops of the capsomere..
10/09/14
20140302064
Optimized anti-cd3 variable regions
The present invention is directed to optimized anti-cd3 variable sequences for use in a variety of bispecific formats, including those that utilize scfv components. The invention further relates to nucleic acids encoding for the polypeptide, to vectors comprising the same and to host cells comprising the vector.
10/09/14
20140302054
Anti-gpr49 antibodies
Described herein are antibodies against gpr49 and uses of such antibodies. Various aspects relate to monoclonal, humanized, or fully human antibodies against gpr49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies..
10/09/14
20140302049
Anti-gpr49 antibodies
Described herein are to antibodies against gpr49 and uses of such antibodies. Various aspects relate to monoclonal, humanized, or fully human antibodies against gpr49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies..
10/09/14
20140302033
Albumin binding antibodies and binding fragments thereof
A serum albumin binding antibody or fragment thereof comprising a heavy chain variable domain having the sequence given in seq id no: 1 or seq id no:2 and/or comprising a light chain variable domain having the sequence given in seq id no:3 or seq id no:4, in particular comprising a heavy chain variable domain and a light chain variable domain having the sequence given in seq id no: 1 and seq id no:3 or a heavy chain variable domain and a light chain variable domain having the sequence given in seq id no: 2 and seq id no:4. The disclosure also extends to polynucleotides encoding the antibodies or fragments, vectors comprising same and host cells capable of expressing the polynucleotides.
10/09/14
20140301992
Compositions, methods and uses for treating solid tumors using lcmv-gp-vsv pseudotype vectors
Embodiments of the present invention relate to compositions and methods for producing recombinant vsv viruses. In accordance with these embodiments, viral vectors can include a glycoprotein gp of the lymphocyte choriomeningitis virus (lcmv) instead of the g protein of the vsv.
10/09/14
20140301974
Extended recombinant polypeptides and compositions comprising same
The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (xten), isolated nucleic acids encoding the compositions and vectors and host cells containing the same, and methods of using such compositions in treatment of glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders and conditions.. .
10/09/14
20140301883
Method and apparatus for producing three-dimensional work pieces
A method for producing three-dimensional work pieces comprises the steps of supplying gas to a process chamber accommodating a carrier and a powder application device, applying a layer of raw material powder onto the carrier by means of the powder application device, selectively irradiating electromagnetic or particle radiation onto the raw material powder applied onto the carrier by means of an irradiation device, discharging gas containing particulate impurities from the process chamber, and controlling the operation of the irradiation device by means of a control unit such that a radiation beam emitted by at least one radiation source of the irradiation device is guided over the layer of raw material powder applied onto the carrier according to a radiation pattern containing a plurality of scan vectors.. .
10/09/14
20140300647
Scaling vector objects having arbitrarily complex shapes
Scaling arbitrarily complex graphical objects is described by superimposing a grid of four guide lines on a graphical object defined by one or more vectors. The guide lines define nine grid sections.
10/09/14
20140300606
Drawing device, drawing method, and drawing program
A drawing device includes an input unit, a first vector calculation unit, a second vector calculation unit, and a display control unit. The input unit accepts user input.
10/09/14
20140298887
Wheeled vehicle rollover performance testing system
This invention is for a simple, dynamic test device and its use to assess a wheeled vehicle's dynamic performance leading to a rollover including such conditions as a curb tripped rollover, a vehicle's occupant restraint performance before and during the first roll, the motion of the vehicle's occupants before and during a rollover, and the vehicle's occupant protection performance in a rollover including its roof crush resistance. It does so by carrying a vehicle over a horizontal circular path at a speed sufficient that the centrifugal force on the vehicle will cause it to roll.
10/02/14
20140298502
Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
The amino acid and nucleic acid sequences of a Δ5-desaturase enzyme and a Δ8-desaturase enzyme are disclosed. The nucleic acid sequences can be used to design recombinant dna constructs and vectors.
10/02/14
20140298351
Parallel operation method and information processing apparatus
An information processing apparatus assigns the calculation of a first submatrix included in a matrix including zero elements and non-zero elements to a first thread and the calculation of a second submatrix included in the matrix to a second thread. The information processing apparatus compares the distribution of non-zero elements in the rows or columns of the first submatrix with the distribution of non-zero elements in the rows or columns of the second submatrix.
10/02/14
20140298049
Digital signal transition counters for digital integrated circuits
A digital integrated circuit may include a digital data processing circuit having multiple signal lines that each go through signal transitions during operation of the digital data processing circuit. A digital counter circuit may count the combined number of signal transitions that take place on at least two of the multiple signal lines during operation of the digital circuit.
10/02/14
20140296932
Systems and methods for sensing vector selection in an implantable medical device
Methods and devices for sensing vector analysis in an implantable cardiac stimulus system. In an illustrative example, a first sensing vector is analyzed to determine whether it is suitable, within given threshold conditions, for use in cardiac event detection and analysis.
10/02/14
20140296930
Cardiac-safe electrotherapy method and apparatus
A multi-modal electrotherapy apparatus including circuitry for administering defibrillation therapy and for administering medium voltage therapy (mvt) adapted to reduce the side effects of mvt. The electrotherapy apparatus is configured to selectively deliver mvt to vectors not involving the ventricles and defibrillation therapy to vectors involving the ventricles.
10/02/14
20140296836
Gold-in-silicon nanoassembly for thermal therapy and methods of use
The present invention provides methods and compositions for the nanotechnology-based therapy of one or more mammalian diseases. Disclosed are gold-in-porous silicon nanoassemblies that are effective in the targeted and localized treatment of one or more human hyperproliferative disorders, including, for example, cancer of the breast.
10/02/14
20140296326
Epidermal growth factor receptor (egfr) and methods of use in adenoviral-associated virus type 6 (aav6) transduction
Comparative gene analysis (cga) was combined with pathway visualization software to identify a positive correlation between aav6 transduction and epidermal growth factor receptor (egfr) expression. It was found that egfr is necessary for vector internalization and functions as a co-receptor for aav6.
10/02/14
20140296324
Vectors harboring toxic genes, methods and uses therefor
The present disclosure describes nucleic acids, and viruses comprising such nucleic acids, for growing a toxic gene in an insect cell. These nucleic acids comprise a sequence encoding a toxic polypeptide, and an intron that interrupts the sequence, whereby the intron is spliced in mammalian cells but not in insect cells.
10/02/14
20140296101
Secreted proteins and uses thereof
The invention also provides antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a nucleic acid molecule of the invention has been introduced or disrupted. The invention still further provides isolated polypeptides, fusion polypeptides, antigenic peptides and antibodies.
10/02/14
20140296093
Use of multiple recombination sites with unique specificity in combinational cloning
The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity.
10/02/14
20140295540
Means for generating adenoviral vectors for cloning large nucleic acids
Wherein the third nucleic acid molecule is either a linear or a circular molecule.. .
10/02/14
20140295526
Modified proteases
This invention relates to modified polynucleotides encoding modified proteases, and methods for altering the production of proteases in microorganisms. In particular, the present invention relates to methods for altering the expression of proteases in microorganisms, such as bacillus species.
10/02/14
20140295502
Cdna synthesis improvements
The present invention generally relates to methods of making cdna molecules and cdna libraries. The invention also relates to cdna molecules and cdna libraries produced according to these methods, as well as to vectors and host cells containing such cdna molecules and libraries.
10/02/14
20140295500
Dna polymerases with improved activity
Disclosed are dna polymerases having increased reverse transcriptase efficiency relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods.
10/02/14
20140295499
Dna polymerases with increased 3'-mismatch discrimination
Disclosed are mutant dna polymerases having increased 3′-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods.
10/02/14
20140295497
Vectors and host cells comprising a modified sv40 promoter for protein expression
The present disclosure is directed to expression vectors, comprising a weakened sv40 promoter, and recombinant mammalian cells capable of producing high levels of a polypeptide of interest, methods of generating and using such recombinant mammalian cells.. .
10/02/14
20140295493
Polypeptides having protease activity and polynucleotides encoding same
The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides..
10/02/14
20140295409
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
The present invention provides an isolated mammalian negative strand rna virus, metapneumovirus (mpv), within the sub-family pneumoviridae, of the family paramyxoviridae. The invention also provides isolated mammalian negative strand rna viruses identifiable as phylogenetically corresponding or relating to the genus metapneumovirus and components thereof.
10/02/14
20140295027
Polypeptides having protease activity
The present invention relates to isolated polypeptides having protease activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides in e.g.
10/02/14
20140294941
Anti-angiogenic compositions and therapeutic applications thereof
There is described the use of the human herpesvirus type 6 (hhv-6) u94 gene and its product, the protein rep, expression vectors and pharmaceutical compositions suitable for the delivery of the u94 gene or the protein encoded therefrom to the therapeutic sites, to inhibit angiogenic and lymphangiogenic processes in a subject in need thereof.. .
10/02/14
20140294895
Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
Vaccines for conferring immunity in mammals to infective pathogens are provided, as well as vectors and methods for plastid transformation of plants to produce protective antigens and vaccines for oral delivery. The invention further provides transformed plastids having the ability to survive selection in both the light and the dark, at different developmental stages by using genes coding for two different enzymes capable of detoxifying the same selectable marker, driven by regulatory signals that are functional in proplastids as well as in mature chloroplasts.
10/02/14
20140294875
Leishmania vaccine using sand fly salivary immunogen
The present invention provides vectors that contain and express in vivo or in vitro sand fly lu. Longipalpis salivary antigens that elicit an immune response in animal or human against leishmania, vaccine compositions comprising said vectors and/or lu.
10/02/14
20140294867
Site-specific antibody-drug conjugation through glycoengineering
The current disclosure provides binding polypeptides (e.g., antibodies), and effector moiety conjugates thereof (e.g., antibody-drug conjugates or adcs), comprising a site-specifically engineered drug-glycan linkage within native or engineered glycans of the binding polypeptide. The current disclosure also provides nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors and host cells for making such antigen-binding polypeptides.
10/02/14
20140294852
Monoclonal antibodies to programmed death 1 (pd-1)
The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to pd-1 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided.
10/02/14
20140294813
Tnf binding proteins
Provided are tnf binding proteins and methods of treatment using the same. Also provided are nucleic acids encoding the binding proteins and recombinant expression vectors and host cells for making such binding proteins..
10/02/14
20140294320
Pull frame interpolation
A method and apparatus for performing pull frame interpolation are provided. Pull frame interpolation may include identifying a plurality of input video frames, generating a plurality of motion vectors indicating motion from a first frame of the plurality of input video frames to a second frame of the plurality of input video frames, identifying an interpolation point between the first frame and the second frame, generating a plurality of candidate interpolation motion vectors indicating motion from the first frame to the interpolation point and from the second frame to the interpolation point based on the plurality of motion vectors, selecting an interpolation motion vector from the plurality of candidate interpolation motion vectors based on a metric, and generating an interpolated frame at the interpolation point based on the selected interpolation motion vector..
10/02/14
20140294083
Method and an apparatus for decoding a video
The present disclosure relates to a method and an apparatus for motion vector encoding/decoding through estimations of multiple motion vectors, and to a method and an apparatus for video encoding/decoding using the same. The disclosure provides a motion vector encoding apparatus including a motion vector estimator for estimating a plurality of motion vectors with estimating one of the plurality of motion vectors as a motion vector of a current block and estimating the remaining motion vectors by one or more predefined estimation criteria in agreement with a video decoding apparatus; and a motion information encoder for encoding motion information generated by using the plurality of motion vectors.
10/02/14
20140294079
Motion vector processing device for clustering motion vectors and method of processing the same
A motion vector processing device includes a motion vector detection unit, a transforming unit, and a clustering processing unit. The motion vector detection unit detects motion vectors from a current image frame and a reference image frame.
10/02/14
20140293955
Predictive spectral allocation in mobile networks
Technologies are generally described for discerning patterns in the “goodness” or “badness” of time-frequency slots to allow predictive allocation of spectral resources that may be appropriate for a wireless user. According to some examples, information on device location, time slots, sub-carrier(s) allotted for each time slot, and quality indicators may be received from mobile devices.
10/02/14
20140293736
Low complexity motion compensating beamforming system and method thereof
A low complexity motion compensating beamforming system utilizes a probe array to fire for beamforming by synthetic apertures. The beamforming range of each firing is a region of interest (roi), and the common area of adjacent roi's forms the common roi.
10/02/14
20140292817
Invisible or low perceptibility of image alignment in dual projection systems
A dual projection system can align displayed images using an alignment pattern. The alignment pattern can be used to modify part of an image content frame of an image data sequence.
10/02/14
20140292574
Selected aspects of advanced receiver autonomous integrity monitoring application to kalman filter based navigation filter
A method of advanced receiver autonomous integrity monitoring of a navigation system is discussed and two modifications facilitating its implementation in a hybrid navigation system are disclosed. In the first approach, relations describing the effect of unmodeled biases in pseudo-measurement on the kalman filter state estimate are analytically derived and their incorporation into the integrity monitoring algorithm is described.
09/25/14
20140289908
Gene combinations for producing punicic acid in transgenic plants
Transgenic plants with enhanced punicic acid accumulation result from over-expression of pgfadx and pgfad2, and optionally, one or more of pgdgat1, pgdgat2, and pgpdat1. The invention also relates to novel isolated punica granatum diacylglycerol acyltransferases: type 1 (pgdgat1), type 2 (pgdgat2) and phospholipid:diacylglycerol acyltransferases (pgpdat1); polynucleotide sequences encoding the dgats and pdat enzymes; polynucleotide constructs, vectors and host cells incorporating the polynucleotide sequences; and methods of producing and using same..
09/25/14
20140289905
Polypeptides having xylanase activity and polynucleotides encoding same
Provided are isolated polypeptides having xylanase activity, catalytic domains and cellulose binding domains, and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains..
09/25/14
20140289879
Production of transgenic avians using improved retroviral vectors
A transgenic avian containing in its genome an exogenous nucleotide sequence which includes a promoter component and a vector with reduced promoter interference wherein the exogenous nucleotide sequence is integrated into the genome and the avian.. .
09/25/14
20140289382
Utilizing version vectors across server and client changes to determine device usage by type, app, and time of day
Technology is disclosed for utilizing version vector data of computing devices to optimize performance of the computing devices and/or other computer systems that provide various services to the computing devices (“the technology”). One embodiment includes analyzing version vectors of the computing devices to determining a user's usage pattern, such as the type of computing device used, the computer applications used on the computing device, and the time of day of usage.
09/25/14
20140288455
Multi-frequency impedance monitoring system
A system and method is provided to measure intrathoracic complex impedance and to identify and indicate disease conditions based on the impedance measurements. Multiple impedance vectors may be taken into account, and an optimal vector may be selected to provide the most useful impedance measurement for the identification and indication of disease conditions..
09/25/14
20140287496
Heat-resistant newcastle disease virus live vaccine vector system and use thereof
A heat-resistant ndv live vaccine vector system includes a transcription plasmid, three helper plasmids, and host cells. The transcription plasmid is constructed by through cloning complete genomic cdna of a heat-resistant ndv vaccine strain to a pbr322 vector.
09/25/14
20140287491
Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended sirna
The present invention provides methods of enhancing the efficacy and specificity of rnai using single or double blunt-ended sirna. The invention also provides single and double-blunt ended sirna compositions, vectors, and transgenes containing the same for mediating silencing of a target gene.
09/25/14
20140287465
Polypeptides having xylanase activity and polynucleotides encoding same
The present invention relates to polypeptides having xylanase activity, catalytic domains, and carbohydrate binding domains, and polynucleotides encoding the polypeptides, catalytic domains, and carbohydrate binding domains. The present invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains, and carbohydrate binding domains..
09/25/14
20140286986
Polypeptides having immunoactivating activity and methods of producing the same
Isolated polypeptides are provided that comprise a cholera toxin b subunit variant having one or more modifications to increase the expression of the polypeptide in a plant cell. Nucleic acids sequences, vectors, and plant cells for expressing the cholera toxin b subunit variant polypeptides are also provided.
09/25/14
20140286973
Chimeric antigen receptor specific for folate receptor beta
The invention provides compositions and methods for treating leukemia, for example, acute myeloid leukemia (aml). The invention also relates to at least one chimeric antigen receptor (car) specific to folate receptor beta (frβ), vectors comprising the same, and recombinant t cells comprising the frβ car.
09/25/14
20140286954
Tau protease compositions and methods of use
Disclosed are mammalian tau proteases, as well as proteolytically-active fragments, variants, and mutants thereof. Also disclosed are polynucleotides and recombinant expression vectors that encode these polypeptides, as well as methods for producing such proteins in selected recombinant host cells, and for using the compositions in a variety of diagnostic and analytical assays..
09/25/14
20140286907
Transient expression vectors, preparation and uses thereof
The present invention describes a recombinant retroviral vector which cannot by itself achieve complete reverse transcription as well as its uses, in particular for transiently transferring in vitro, ex vivo or in vivo at least one ribonucleic acid sequence of interest in a cell. Such a transient transgene expression is of interest in the context of research, therapy and more generally in the field of biotechnology..
09/25/14
20140286861
Rs7 antibodies
This invention relates to monovalent and multivalent, monospecific binding proteins and to multivalent, multispecific binding proteins. One embodiment of these binding proteins has one or more binding sites where each binding site binds with a target antigen or an epitope on a target antigen.
09/25/14
20140286589
Method for coding a sequence of digital images
A method codes a sequence of digital images, each image having the same image format and including a number of pixels with assigned pixel values. Motion parameters between first and second images are determined, where based on said motion parameters a motion compensation is performed for coding the sequence of images, where said motion parameters are included in the coded sequence of images.
09/25/14
20140286577
Image registration device and operation method of the same
Provided is an image registration device including a first feature vector magnitude calculating unit calculating magnitudes of feature vectors corresponding to any one first feature point among feature points of a reference image to create a first magnitude value, a second feature vector magnitude calculating unit calculating magnitudes of feature vectors corresponding to any one second feature point among feature points of a target image to create a second magnitude value, a magnitude difference calculating unit receiving the first and second magnitude values and calculating a difference between the received first and second magnitude values to create a third magnitude value, a first threshold value creating unit creating a first threshold value on the basis of the first magnitude value and a magnitude ratio, and a magnitude difference determining unit receiving the third magnitude value and the first threshold value, and determining a magnitude difference.. .
09/25/14
20140286459
Multi-mode orthogonal frequency division multiplexing receiver for highly-spectrally-efficient communications
A receiver may comprise a sequence estimation circuit and operate in at least two modes. In a first mode, the sequence estimation circuit may process ofdm symbols received on a first number of data-carrying subcarriers to recover a number of mapped symbols per ofdm symbol that is greater than the first number.
09/25/14
20140286441
Video quality measurement
A particular implementation receives a bitstream and derives parameters from the bitstream. The parameters include quantization parameters, content unpredictability parameters, ratios of lost blocks, ratios of propagated blocks, error concealment distances, motion vectors, durations of freezing, and frame rates.
09/25/14
20140286423
Disparity vector derivation in 3d video coding for skip and direct modes
A video decoder performs a neighboring-block based disparity vector (nbdv) derivation process to determine a disparity vector or performs a nbdv refinement (nbdv-r) process to determine the disparity vector. The video decoder uses the disparity vector as a disparity vector for a current block without using a median filtering process on multiple disparity motion vectors, wherein the current block is coded in either a skip mode or a direct mode.
09/25/14
20140286410
System and method for non-uniform video coding
A method and system for video coding by integrating frame data and time data may be described. The method and system can include a video coding non-transitory storage media that integrates reference data and time data.
09/25/14
20140286409
Enhanced reference region utilization for scalable video coding
Techniques to identify one or more candidate reference blocks used to generate a prediction block to encode a current coding block. The candidate reference blocks can be in the same layer as the current coding block or a different layer.


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Vectors for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vectors with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3711

3996

5 - 0 - 93